WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Monday, October 30, 2017

FoxFeed Blog: Broader MJFF-23andMe Collaboration Seeks to Drive Advances through PD Genetics

Posted by Holly Teichholtz,   October 30, 2017


The Michael J. Fox Foundation today announced a new initiative in collaboration with personal genetics company 23andMe to gather genetic data for Parkinson's research through the Fox Insight platform. MJFF also is partnering with 23andMe on a series of pilot initiatives to explore and optimize varied uses of genetic data for scientific discovery.
With funding from MJFF, 23andMe researchers will use genetic data collected through the company's PD Research Community from 2009-2017 to gain new genotypic and phenotypic insights about Parkinson's. These collaborations include:
  • 23andMe Community Analyses -- The goal of this collaboration is to mine data collected through the 23andMe PD community for genotypic and phenotypic insights, including exploring novel phenotypes associated with PD, identifying potential PD subtypes and illuminating potential gene-environment interactions that may play a role in Parkinson's pathology.
  • Medical Records -- This collaboration will explore the collection of medical record data (for example electronic medical records) and their use in conjunction with the 23andMe PD community to determine whether participants are willing to share medical data, if it is cost-effective to collect, and if it adds value to existing data sets.
  • Microbiome Pilot Study -- Some evidence has linked alterations in gut bacteria to Parkinson's disease (PD). This pilot study will explore the viability and value of microbiome sample collection and analysis from the 23andMe PD community. Goals include determining feasibility of sample collection, exploring the replicability of reported microbiome differences in PD vs health controls and correlating potential microbiome composition differences in PD cases against various phenotypic and/or genotypic features.
  • Off-Label Drug Use Survey -- This study will survey the 23andMe PD community for insight on use and access to off-label drugs for treating Parkinson's disease.

https://www.michaeljfox.org/foundation/news-detail.php?broader-mjff-23andme-collaboration-seeks-to-drive-advances-through-pd-genetics-8232

No comments:

Post a Comment